Lombard Odier Asset Management (Switzerland) SA
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1535660
PETIT-LANCY, V8
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$969,316
-$129,172 QoQ
Shares Held
3,220
-3.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#403
of 784 holders
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lombard Odier Asset Management (Switzerland) SA holds $9,106,243 across 6 Biotechnology names. ALNY ranks #3 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,072 | $4,506,334 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,314 | $2,066,411 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
3,220 | $969,316 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,832 | $904,936 | |
| 5 | RPRX |
Royalty Pharma plc
|
7,133 | $399,947 | |
| 6 | INSM |
INSMED Inc
|
2,432 | $259,299 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $969,316 | 3,220 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,098,488 | 3,320 | Shares | Other | 2026-05-15 | |
| 2023-03-31 | $15,244,952 | 76,103 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $13,483,785 | 56,738 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $7,128,298 | 35,613 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $6,724,268 | 46,104 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $13,559,275 | 83,038 | Shares | Other | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||